Assessing New Symptoms in People with Cancer in Primary Care

When a patient with a history of cancer presents to doctors with a new or changing symptom, recurrence is often the first concern for both the patient and the doctor. Effective care for these patients requires navigating four competing possibilities, which frequently coexist:

• Cancer recurrence

• A second primary malignancy

• Late or chronic treatment effects

• An entirely unrelated medical condition.

Primary care plays a central role in detecting recurrence. Many patients first present in primary care even when they are under follow-up by hospital specialists. Yet, doctors face practical barriers, including difficult-to-access treatment summaries, unclear shared-care boundaries, and unfamiliarity with specific late treatment toxicities. Moreover, diagnostic recognition does not automatically translate into appropriate action: clinicians may identify a plausible diagnosis but still struggle with subsequent referral thresholds, non-recommended surveillance investigations, or coordination hurdles.

A Five-Task Framework for Consultations

To structure diagnostic reasoning and clinical decision-making, we propose a practical five-stage framework:

1. Define What Has Changed: Distinguish longstanding post-treatment symptoms from genuine new functional decline, altered symptom trajectories, or specific red flags.

2. Retrieve Decision-Critical Information: Identify specific past exposures (e.g., radiotherapy, chemotherapy or immunotherapy) and current maintenance therapies; formulate targeted information requests to oncology if records are absent.

3. Compare Plausible Explanations: Actively evaluate recurrence, new malignancy, late toxicities, and unrelated illness side-by-side, rather than defaulting immediately to anxiety or closure.

4. Choose and Explain Proportionate Action: Link every investigation or referral to an explicit clinical question; avoid non-targeted routine screening tests while escalating urgent red flags promptly.

5. Assign Explicit Follow-Up Responsibility: Agree clear safety-netting triggers, designate who is chasing and reviewing test results, and clarify access pathways back into secondary oncology care.

Based on: Jerjes W, Ahmad V, Khider S, et al. Cancer, Treatment Effect or Something Else? A Narrative Review of Symptom Assessment and Continuing Education in Primary Care. J Cancer Educ (2026).